文献速递其他结缔组织病血管炎

新加坡系统性硬化症队列中间质性肺病与肺动脉高压的死亡和住院结局

Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
PubMed 文献 · Semin Arthritis Rheum · 2019-11-13

该研究在新加坡系统性硬化症队列(SCORE)490例患者中比较了孤立性肺动脉高压(PAH)、间质性肺病(ILD)、ILD合并肺动脉高压(ILD-PH)及无/轻度肺部受累四组的死亡与住院率。结果显示ILD-PH死亡风险最高(HR 3.77),其次为PAH(HR 3.03)和ILD(HR 1.84);多因素校正后仅PAH与死亡率独立相关(HR 2.39)。住院率增加与肾危象、右心衰竭和PAH药物相关,而与SSc分组无关。

要点

  • ILD-PH患者死亡风险最高(HR 3.77),其次为PAH(HR 3.03)和ILD(HR 1.84)。
  • 多因素校正后PAH仍为死亡的独立危险因素(HR 2.39)。
  • 住院率增加与肾危象、右心衰竭及PAH药物相关,与SSc分组无关。

核心结论

  • PAH是系统性硬化症患者死亡的独立危险因素。
  • 住院率增加与肾危象、右心衰竭和PAH药物相关,而与SSc分组无关。

研究设计与样本

  • 基于新加坡系统性硬化症队列(SCORE)的回顾性队列研究,共纳入490例SSc患者。
  • ILD经HRCT诊断,显著ILD定义为用力肺活量<70%预计值。
  • PAH定义为超声估测肺动脉收缩压≥50 mmHg或右心导管平均肺动脉压≥25 mmHg。
  • 采用多因素回归分析死亡与年住院率相关因素,Cox比例风险模型分析生存。

主要发现

  • 490例中,PAH 50例,ILD 92例,ILD-PH 43例;93例PAH或ILD-PH中56例基于超声、37例基于右心导管诊断。
  • ILD-PH死亡风险HR 3.77(95%CI 2.05-6.93),PAH HR 3.03(95%CI 1.60-5.76),ILD HR 1.84(95%CI 1.04-3.28)。
  • 多因素校正后PAH仍与死亡率独立相关(HR 2.39,95%CI 1.13-5.07),ILD-PH和ILD则未显示独立关联。
  • 其他与死亡相关的因素包括男性、SSc诊断时年龄、吸收不良和指端溃疡/坏疽。
  • 住院率增加与肾危象、右心衰竭和PAH药物相关,但与SSc分组无关。

关键数值与推荐

  • 显著ILD定义:用力肺活量<70%预计值。
  • PAH定义:超声估测肺动脉收缩压≥50 mmHg或右心导管平均肺动脉压≥25 mmHg。
  • 死亡风险:ILD-PH HR 3.77(95%CI 2.05-6.93),PAH HR 3.03(95%CI 1.60-5.76),ILD HR 1.84(95%CI 1.04-3.28)。
  • 多因素校正后PAH与死亡独立相关:HR 2.39(95%CI 1.13-5.07)。

临床怎么用

  • 对SSc患者应筛查并监测PAH,因其为独立死亡危险因素。
  • ILD-PH患者死亡风险最高,需加强管理。
  • 关注肾危象、右心衰竭及PAH药物使用对住院风险的影响。
  • 男性、诊断时年龄、吸收不良和指端溃疡/坏疽也提示死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compared mortality and hospitalization rates in four groups of patients with systemic sclerosis (SSc) [isolated pulmonary arterial hypertension (PAH) or interstitial lung disease (ILD), concomitant ILD-pulmonary hypertension (PH), and no/mild pulmonary involvement]. METHODS: In the Systemic Sclerosis Cohort Singapore (SCORE), ILD was diagnosed by HRCT and significant ILD was defined by forced vital capacity <70% predicted. Patients were classified as PAH if echocardiographic systolic pulmonary artery pressure (sPAP) ≥50 mmHg or right heart catheterization (RHC) mean PAP ≥25 mmHg. Multivariable regression analyses were performed to determine factors associated with mortality and hospital admissions per year. Cox proportional hazard model was used to analyze survival. RESULTS: Of 490 SSc patients, 50 patients had PAH, 92 patients had ILD and 43 patients had ILD-PH. Of 93 patients with PAH or ILD-PH, 56 were based on echocardiography and 37 on RHC. Patients with ILD-PH (HR 3.77, 95% CI: 2.05-6.93) had the highest risk of death, followed by PAH (HR 3.03, 95% CI: 1.60-5.76) and ILD (HR 1.84, 95% CI: 1.04-3.28). After adjustment for confounders, PAH (HR 2.39, 95% CI: 1.13-5.07) remained independently associated with mortality, but not ILD-PH or ILD. Other factors associated with mortality were male gender, age at SSc diagnosis, malabsorption and digital ulcer/ gangrene. Increased hospitalization rate was associated with renal crisis, right heart failure and PAH medications, but not SSc groups. CONCLUSION: PAH is an independent risk factor of mortality in SSc. Increased hospitalization rate was not associated with SSc groups. Other factors associated with increased mortality and hospital admissions were identified.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Noviani M, Saffari SE, Tan JL, et al. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort. Semin Arthritis Rheum. 2019. PMID: 31810742. doi:10.1016/j.semarthrit.2019.11.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。